Table 1.
Laboratory blood test results
| Laboratory results | All patients (n = 135) | Non-severe group (n = 123) | Progress-to-severe group (n = 12) | P value* |
|---|---|---|---|---|
| Hemoglobin (g/dL) | 13.8 ± 1.8 | – | – | – |
| Decreased—n (%) | 69 (53.3) | 66 (59.1) | 3 (25) | 0.116 |
| White blood cell count (×109/L) | 5.4 ± 1.7 | – | – | – |
| İncreased—n (%) | 3 (2.2) | 3 (2.4) | 0 | 0.230 |
| Decreased—n (%) | 24 (17.8) | 21 (17.1) | 3 (25) | 0.805 |
| Neutrophil count (×109/L) | 2.94 (1.34–7.71) | – | – | – |
| İncreased—n (%) | 9 (6.7) | 9 (7.3) | 0 | 0.232 |
| Decreased—n (%) | 18 (13.3) | 15 (12.2) | 3 (25) | 0.470 |
| Lymphocyte count (×109/L) | 1.6 ± 0.6 | – | – | – |
| Decreased—n (%) | 45 (33.3) | 39 (31.7) | 6 (50) | 0.403 |
| Monocyte count (×109/L) | 0.4 (0.11–2.33) | – | – | – |
| İncreased—n (%) | 6 (4.4) | 6 (4.9) | 0 | 0.210 |
| Decreased—n (%) | 30 (22.2) | 27 (22) | 3 (25) | 0.813 |
| Platelet count (×109/L) | 198.5 ± 61.6 | – | – | – |
| Decreased—n (%) | 24 (17.8) | 24 (19.4) | 0 | 0.193 |
| C‑reactive protein (mg/L) | 4.40 (0.33–34.30) | – | – | – |
| İncreased—n (%) | 66 (48.9) | 57 (46.3) | 9 (75) | 0.058 |
| Alanine aminotransferase (U/L) | 24 (10–66) | – | – | – |
| İncreased—n (%) | 24 (17.8) | 24 (19.5) | 0 | 0.085 |
| Aspartate aminotransferase (U/L) | 19 (8–141) | – | – | – |
| İncreased—n (%) | 15 (11.1) | 15 (12.2) | 0 | 0.228 |
| Bilirubin (μmol/L) | 0.36 (0.16–1.45) | – | – | – |
| İncreased—n (%) | 3 (2.2) | 3 (2.4) | 0 | 0.222 |
| Urea (mmol/L) | 26.6 ± 9.9 | – | – | – |
| İncreased—n (%) | 3 (2.2) | 3 (2.4) | 0 | 0.241 |
| Lactate dehydrogenase (U/L) | 217.9 ± 63.7 | – | – | – |
| İncreased—n (%) | 45 (33.3) | 36 (29.3) | 9 (75) | 0.011 |
* p-value ≤ 0.05